Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 8 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 11479613

    Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins

    AUTOLUS LIMITED · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  2. US 11479614

    Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors

    AUTOLUS LIMITED · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  3. US 11472884

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  4. US 11473060

    Compositions and methods for differentiating stem cells into NK cells

    CRISPR THERAPEUTICS AG · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  5. US 11471491

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  6. US 11464807

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  7. US 11458212

    Molecular imaging of cancer cells in vivo

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  8. US 11459560

    Methods and compositions for reprogramming cells

    The Regents of the University of Colorado · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  9. US 11459372

    Gene-edited natural killer cells

    CRISPR THERAPEUTICS AG · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  10. US 11458171

    Engineering stem cells for cancer therapy

    China Medical University · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  11. US 11453861

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Precision BioSciences, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  12. US 11446357

    Method for treating disease using FOXP3+CD4+ T cells

    Kyverna Therapeutics, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  13. US 11446302

    Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  14. US 11441184

    Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  15. US 11434505

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  16. US 11433103

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  17. US 11419883

    Inhibiting senescent processes in beta cells for the prevention of type 1 diabetes

    The Regents of the University of California · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted
  18. US 11421010

    T cells expressing membrane-anchored IL-12 for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted
  19. US 11400118

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  20. US 11401510

    Generation of airway basal stem cells from human pluripotent stem cells

    The Board of Regents of the University of Texas System · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  21. US 11400116

    Systems and methods for targeting cancer cells

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  22. US 11390884

    Optimized CRISPR/cas9 systems and methods for gene editing in stem cells

    Editas Medicine, Inc. · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  23. US 11390921

    Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)

    Adaptive Biotechnologies Corporation · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  24. US 11390848

    Materials and methods for modifying the activity of T cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted